Cargando…
Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients
BACKGROUND & OBJECTIVES: There is a need for an affordable, easy, high-sensitivity test usable at the peripheral health facility for diagnosis of drug-resistant (DR) tuberculosis (TB) to interrupt disease transmission. Nucleic acid amplification tests (NAATs) for early detection of DR-TB are ide...
Autores principales: | Gomathi, N.S., Singh, Manjula, Myneedu, V.P., Chauhan, D.S., Tripathy, Srikanth, Sarin, Rohit, Mohan, Anant, Bhatnagar, Anuj, Khangembam, Jiten Singh, Kannan, T., Rao, M.V.V., Logani, Jyoti, Dey, Bindu, Gangakhedkar, R.R., Swaminathan, Soumya, Singh, Urvashi B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157890/ https://www.ncbi.nlm.nih.gov/pubmed/33707390 http://dx.doi.org/10.4103/ijmr.IJMR_2557_19 |
Ejemplares similares
-
Multicentric validation of indigenous molecular test Truenat™ MTB for detection of Mycobacterium tuberculosis in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards
por: Gomathi, N.S., et al.
Publicado: (2020) -
Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
por: Araya, Shambel, et al.
Publicado: (2020) -
Trends in rifampicin resistance among patients with presumptive TB in the pre-COVID and COVID-era
por: Alao, Michael Abel, et al.
Publicado: (2022) -
Trends in Rifampicin Resistance Among Children With Presumptive TB in the Pre-COVID and COVID-Era
por: Alao, Michael Abel, et al.
Publicado: (2023) -
INCIDENCE OF RIFAMPICIN-RESISTANCE PRESUMPTIVE M. TUBERCULOSIS CASES AMONG OUTPATIENTS IN KEBBI STATE, NIGERIA
por: Danlami, Mohammed Bashar, et al.
Publicado: (2020)